Alert: Packaging World now enhanced for the iPad and iPhone. Watch a quick video preview
 
Download Download this free, 150-page Pharmaceutical Serialization Playbook jam-packed with strategies for success and pitfalls to avoid.  Learn more >>
Article |

Anticounterfeiting: the urgency grows (sidebear)

Authentication through DNA codes
Print Reprint
FILED IN:  Machinery  > Labeling
     

Bristol-Myers Squibb is among the first pharmaceutical companies to use DNA codes to fight counterfeit drug packaging. For more than a year the company has been labeling anticancer drugs with DNA codes. According to Germany’s identif GmbH a subsidiary of november AG the codes make pharmaceutical packaging “forgery-proof.”

Each code is a unique sequence of synthetic DNA. For a label like the one shown here the DNA is mixed with a clear varnish laid down on the label substrate in one station of a flexo or offset press. The DNA can also be added directly to a folding carton for example by mixing it with the ink sprayed on by an ink-jet printer.

In either case the customer-specific DNA code can be authenticated within seconds by using a hand-held reader like the one shown here. If the reader does not detect the genetic code that is supposed to be on the label or carton a counterfeit has been detected.

New York-based Bristol-Myers Squibb says it will introduce these “genetic fingerprints” for its anticancer drugs and HIV drugs.

See the story that goes with this sidebar: Anticounterfeiting: the urgency grows

Comments(0)

Add new comment

ADVERTISEMENT
E-BOOK SPECIAL REPORT
42 Best Package Designs
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!
x

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
Each newsletter ranges in frequency from once per month to a few times per month at most.